Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin in Type 2 Diabetes Mellitus
NCT01608724Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Nov 2012; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01608724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608724.